Blagosklonny Mikhail V
Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Oncoscience. 2022 Apr 22;9:13-16. doi: 10.18632/oncoscience.552. eCollection 2022.
Some visionaries prefer to dream of immortality rather than to actually live longer. Here I discuss how combining rapamycin with other modalities may let us live long enough to benefit from future discoveries in cellular reprogramming and what needs to be done at Atlos Labs to make this happen.
一些空想家更愿意梦想长生不老,而不是实际活得更长。在此我将探讨将雷帕霉素与其他方法相结合如何能让我们活得足够长久,从而受益于细胞重编程领域未来的发现,以及阿特洛斯实验室需要做些什么来实现这一目标。